Merck & Co., Inc. (MRK)
115.61
-0.30
(-0.26%)
USD |
NYSE |
Mar 13, 16:00
115.61
0.00 (0.00%)
After-Hours: 20:00
Merck Shareholders Equity (Quarterly) : 52.61B for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amgen, Inc. | 8.658B |
| Biogen, Inc. | 18.26B |
| Gilead Sciences, Inc. | 22.70B |
| Regeneron Pharmaceuticals, Inc. | 31.26B |
| Moderna, Inc. | 8.65B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 136.87B |
| Total Liabilities (Quarterly) | 84.20B |
| Debt to Equity Ratio | 0.9606 |
| Current Ratio | 1.536 |
| Net Debt Paydown Yield | -0.95% |